Switch theme
Sign up to access all valuation multiples
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.
2018
59
LTM Revenue n/a
LTM EBITDA -$11.9M
$73.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Affluent Medical has a last 12-month revenue of n/a and a last 12-month EBITDA of -$11.9M.
In the most recent fiscal year, Affluent Medical achieved revenue of n/a and an EBITDA of -$14.1M.
Affluent Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Affluent Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | -$2.7M | -$2.6M | XXX | XXX | XXX |
| Gross Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| EBITDA | -$12.7M | -$14.1M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$15.9M | -$16.4M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | $7.6M | $15.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Affluent Medical's stock price is EUR 1 (or $1).
Affluent Medical has current market cap of EUR 51.9M (or $55.8M), and EV of EUR 68.0M (or $73.0M).
See Affluent Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $73.0M | $55.8M | XXX | XXX | XXX | XXX | $-0.58 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Affluent Medical has market cap of $55.8M and EV of $73.0M.
Affluent Medical's trades at n/a LTM EV/Revenue multiple, and -6.1x LTM EBITDA.
Analysts estimate Affluent Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Affluent Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $73.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -5.2x | XXX | XXX | XXX |
| P/E | -3.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -5.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAffluent Medical's NTM/LTM revenue growth is Infinity%
Affluent Medical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Affluent Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Affluent Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Affluent Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Affluent Medical acquired XXX companies to date.
Last acquisition by Affluent Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Affluent Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Affluent Medical founded? | Affluent Medical was founded in 2018. |
| Where is Affluent Medical headquartered? | Affluent Medical is headquartered in France. |
| How many employees does Affluent Medical have? | As of today, Affluent Medical has 59 employees. |
| Is Affluent Medical publicy listed? | Yes, Affluent Medical is a public company listed on PAR. |
| What is the stock symbol of Affluent Medical? | Affluent Medical trades under AFME ticker. |
| When did Affluent Medical go public? | Affluent Medical went public in 2021. |
| Who are competitors of Affluent Medical? | Similar companies to Affluent Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Affluent Medical? | Affluent Medical's current market cap is $55.8M |
| What is the current EBITDA of Affluent Medical? | Affluent Medical's last 12-month EBITDA is -$11.9M. |
| What is the current EV/EBITDA multiple of Affluent Medical? | Current EBITDA multiple of Affluent Medical is -6.1x. |
| Is Affluent Medical profitable? | Yes, Affluent Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
